Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
about
Rejuvenating sirtuins: the rise of a new family of cancer drug targetsIdentifying vaccine targets for anti-leishmanial vaccine developmentSirtuins of parasitic protozoa: in search of function(s).Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma brucei.Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death.HDAC inhibitors in parasitic diseases.Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos.Schistosome sirtuins as drug targets.Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in vitro and in vivo studies.Structural insights of SIR2rp3 proteins as promising biotargets to fight against Chagas disease and leishmaniasis.Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors.Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.Inhibition of NAD+-dependent histone deacetylases (sirtuins) causes growth arrest and activates both apoptosis and autophagy in the pathogenic protozoan Trypanosoma cruzi.Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.Novel lead compounds in pre-clinical development against African sleeping sickness
P2860
Q30570951-0D324341-D62A-459F-B3A4-8FC43CC87A2CQ33693899-F2B1FA9E-19C6-4E92-AE26-188F50BBC08DQ36357683-F2DAB8FF-94B9-4748-A044-E66C0F522AB4Q36730072-C9058114-7AF2-4D01-B797-0006A6FA47B1Q37810344-73759A31-D7C0-40F7-9D6A-32C784E232F3Q37962336-926C1536-DA8B-48AF-B956-896E00C3E6AEQ38154629-2C39574D-35C5-4646-84B5-CC63FB5B8BD1Q38495049-57725215-9934-4574-BD44-EDD0E3F2EC6FQ38891993-CF59EC4B-6BE6-4940-9DBD-2A08809AD9ECQ39311884-D5A541AA-80BD-4357-B70E-A7A67F9DA74EQ39396789-C8A38C8F-3ECD-4233-A41B-67A6D5437D12Q40394427-B3187D06-89A0-421C-851F-1D2FE3F511CFQ42041049-BE62115C-40E7-4251-B741-EF0FA5C40996Q42222177-0F4F991B-2233-463B-BFA1-24F8E1C4BE7CQ47719317-1B5147C1-241B-41EF-BC22-5162118D0D95Q58842335-4F85C72E-973C-4800-8E53-40F42CAFC2FB
P2860
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
@en
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
@nl
type
label
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
@en
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
@nl
prefLabel
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
@en
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
@nl
P2093
P50
P356
P1433
P1476
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1
@en
P2093
Ali Ouaissi
Inês Loureiro
Paul Kong Thoo Lin
P304
P356
10.1002/CMDC.200900367
P577
2010-01-01T00:00:00Z